Cross purposes

The UK insurer’s 5 bln stg offer for its rival’s general insurance assets has been dismissed as too low. Aviva’s capital structure means it would need a higher price to justify a sale. But RSA has limited scope to raise its equityfunded deal without undermining its own returns.